Dr Ronald A. DePinho
Dr. Ronald A. DePinho is a distinguished university professor and past president at MD Anderson Cancer Center. Ron is a global health leader, entrepreneur, physician and leading scientist in the fields of cancer and aging. In addition to his research, he has launched 3 biotech companies (Tvardi, Asylia, and Nirogy) focused on cancer, inflammation and fibrosis, with potential applications to COVID-19.
Contributions:
Cancer Research and Investment Opportunities
June 11, 2021 expert analysis
Cancer exacts a steep social and economic toll, especially as an aging world population creates increased cancer rates…